WIRF Supported Researcher

Dr Jonathan Davis

Overview

Dr Jonathan Davis is a clinician-researcher, neonatologist, and Medical Director of NETS WA whose research focuses on improving outcomes for critically ill newborns. His work investigates neonatal physiology during critical illness and transport, generating evidence to inform clinical practice and enhance survival and long-term neurodevelopmental outcomes for vulnerable infants.

Dr Jonathan Davis

For 50 years, WIRF has conducted and supported research to improve the health of women, babies and families

Dr Jonathan Davis is a clinician-researcher and neonatologist whose work is driven by a desire to improve outcomes for critically ill newborn infants. As Medical Director of NETS WA, he combines frontline neonatal transport practice with research aimed at understanding the physiological challenges faced by newborns during critical illness and transport, with the goal of translating this knowledge into better care and improved outcomes. His clinical and academic interests span neonatal transport and the care of vulnerable preterm infants and babies who have experienced a lack of oxygen at birth, with a particular focus on how physiological instability influences short- and long-term outcomes.

Embedded in day-to-day clinical practice, Jonathan’s research seeks to advance understanding of neonatal physiology in real-world transport and intensive care settings. His work has examined outcomes in high-risk neonatal populations, including the impact of place of birth on preterm infant outcomes. Through a combination of clinical investigation, translational research, and collaborative multidisciplinary studies, he aims to generate evidence that informs neonatal care and transport practice. Ultimately, his goal is to improve survival and neurodevelopmental outcomes for newborn infants by deepening our understanding of the physiological processes that occur during critical illness and transport.

Preterm birth prevention program lowers rate of early births by up to 10%.

Enable us to fund innovative research and vital support services

Our partners and sponsors

We are proud to work with leading organisations and sponsors who support our mission.